HK1211234A1 - Solid unit with high fexofenadine content and process for the preparation thereof - Google Patents

Solid unit with high fexofenadine content and process for the preparation thereof

Info

Publication number
HK1211234A1
HK1211234A1 HK15112148.9A HK15112148A HK1211234A1 HK 1211234 A1 HK1211234 A1 HK 1211234A1 HK 15112148 A HK15112148 A HK 15112148A HK 1211234 A1 HK1211234 A1 HK 1211234A1
Authority
HK
Hong Kong
Prior art keywords
preparation
solid unit
fexofenadine
content
fexofenadine content
Prior art date
Application number
HK15112148.9A
Other languages
English (en)
Chinese (zh)
Inventor
Baptiste Merillon
Jean-Yves Lanne
Marie Renouard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47902228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1211234(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1211234A1 publication Critical patent/HK1211234A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15112148.9A 2012-12-21 2015-12-09 Solid unit with high fexofenadine content and process for the preparation thereof HK1211234A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1262647A FR2999937B1 (fr) 2012-12-21 2012-12-21 Unite solide a haute teneur en fexofenadine et son procede de preparation
PCT/EP2013/077752 WO2014096387A1 (en) 2012-12-21 2013-12-20 Solid unit with high fexofenadine content and process for the preparation thereof

Publications (1)

Publication Number Publication Date
HK1211234A1 true HK1211234A1 (en) 2016-05-20

Family

ID=47902228

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112148.9A HK1211234A1 (en) 2012-12-21 2015-12-09 Solid unit with high fexofenadine content and process for the preparation thereof

Country Status (25)

Country Link
US (1) US9757340B2 (ko)
EP (1) EP2934491B1 (ko)
JP (1) JP6276287B2 (ko)
KR (1) KR20150100725A (ko)
CN (1) CN105073101B (ko)
AR (1) AR094146A1 (ko)
AU (1) AU2013366512B2 (ko)
BR (1) BR112015014137B8 (ko)
CA (1) CA2895607A1 (ko)
CL (1) CL2015001681A1 (ko)
EA (1) EA030982B1 (ko)
ES (1) ES2625447T3 (ko)
FR (1) FR2999937B1 (ko)
HK (1) HK1211234A1 (ko)
HU (1) HUE032393T2 (ko)
IL (1) IL239267A0 (ko)
MX (1) MX360047B (ko)
PH (1) PH12015501377A1 (ko)
PL (1) PL2934491T3 (ko)
SG (1) SG11201504394TA (ko)
TN (1) TN2015000267A1 (ko)
TW (1) TWI624275B (ko)
UY (1) UY35235A (ko)
WO (1) WO2014096387A1 (ko)
ZA (1) ZA201504079B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015138710A (ru) 2013-02-14 2017-03-20 Санофи Жевательная композиция для перорального приема и способ ее получения
TW201717949A (zh) * 2015-10-29 2017-06-01 日本臟器製藥股份有限公司 以非索非那定為有效成分之錠劑
WO2021182467A1 (ja) 2020-03-11 2021-09-16 沢井製薬株式会社 顆粒及びそれを用いた製剤
WO2023145871A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法
WO2023145869A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044319C (zh) * 1984-08-30 1999-07-28 默里尔多药物公司 热熔融抗组胺组合物的制备方法
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
DE69624559T2 (de) 1995-02-28 2003-07-10 Aventis Pharma Inc Arzneizubereitungen für piperidinalkanolderivate
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
ATE381350T1 (de) * 2003-03-07 2008-01-15 Ind Swift Ltd Geschmacklose, direkt verpressbare, schnelllösliche komplexe und ihre pharmazeutischen zusammensetzungen.
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
RU2015138710A (ru) 2013-02-14 2017-03-20 Санофи Жевательная композиция для перорального приема и способ ее получения

Also Published As

Publication number Publication date
TN2015000267A1 (en) 2016-10-03
EP2934491B1 (en) 2017-02-22
UY35235A (es) 2014-07-31
SG11201504394TA (en) 2015-07-30
AR094146A1 (es) 2015-07-15
JP2016511223A (ja) 2016-04-14
TWI624275B (zh) 2018-05-21
BR112015014137A2 (pt) 2017-07-11
IL239267A0 (en) 2015-07-30
PH12015501377A1 (en) 2015-09-02
EA201591150A1 (ru) 2015-11-30
CN105073101B (zh) 2018-10-09
CA2895607A1 (en) 2014-06-26
BR112015014137B8 (pt) 2023-01-24
MX360047B (es) 2018-10-19
ZA201504079B (en) 2016-04-28
HUE032393T2 (en) 2017-09-28
ES2625447T3 (es) 2017-07-19
CL2015001681A1 (es) 2015-08-21
JP6276287B2 (ja) 2018-02-07
FR2999937A1 (fr) 2014-06-27
FR2999937B1 (fr) 2015-01-09
PL2934491T3 (pl) 2017-09-29
MX2015008068A (es) 2016-04-25
TW201431569A (zh) 2014-08-16
CN105073101A (zh) 2015-11-18
US9757340B2 (en) 2017-09-12
AU2013366512B2 (en) 2017-11-09
BR112015014137B1 (pt) 2022-12-13
KR20150100725A (ko) 2015-09-02
WO2014096387A1 (en) 2014-06-26
EP2934491A1 (en) 2015-10-28
AU2013366512A1 (en) 2015-07-09
EA030982B1 (ru) 2018-10-31
US20150313885A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
HK1215817A1 (zh) 內容遞送框架
EP2867896A4 (en) RHYTHM OF CONTENT
SG11201404870YA (en) Process for the preparation of polypropylene with low ash content
EP2885662A4 (en) IMPROVED MATERIAL STUDY
EP2934454C0 (en) ANTI-DANDRUFF COMPOSITION
GB201104542D0 (en) Content provision
EP2808681A4 (en) breathalyser
SG11201405261TA (en) Bio-polyols for bio-lubricant and bio-polymer and methods for the preparation thereof
EP2898625A4 (en) CONSCIOUS CONTENT DISTRIBUTION OF CONTEXT
IL229684A (en) Screw
HK1204961A1 (en) Solid pharmaeutical preparation containing levothyroxine
HK1211234A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
EP2943893A4 (en) PROVISION OF ORGANIZED CONTENT
IL235805A (en) Pyrimidinyl-Diazaspiro compound and process for preparation
IL229432A0 (en) Chondroitin sulfate domi-shark and a process for its preparation
GB201205477D0 (en) Content distribution
EP2899254A4 (en) BIOCOMBUSTIBLE PRODUCT AND METHOD OF OBTAINING
GB201217004D0 (en) Improvements in resolving video content
HK1180202A1 (zh) 泡茶工藝及其專用泡茶裝置
GB201213778D0 (en) Process and dressng
PL398018A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
PL398021A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
GB201222736D0 (en) Composition and process
ZA201308457B (en) Shark-like chondroitin sulphate and process for the preparation thereof
PL398022A1 (pl) Nowy fosfolipid i sposób jego otrzymywania

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211218